1.Pathological Networks Involving Dysmorphic Neurons in Type II Focal Cortical Dysplasia.
Yijie SHAO ; Qianqian GE ; Jiachao YANG ; Mi WANG ; Yu ZHOU ; Jin-Xin GUO ; Mengyue ZHU ; Jiachen SHI ; Yiqi HU ; Li SHEN ; Zhong CHEN ; Xiao-Ming LI ; Jun-Ming ZHU ; Jianmin ZHANG ; Shumin DUAN ; Jiadong CHEN
Neuroscience Bulletin 2022;38(9):1007-1024
Focal cortical dysplasia (FCD) is one of the most common causes of drug-resistant epilepsy. Dysmorphic neurons are the major histopathological feature of type II FCD, but their role in seizure genesis in FCD is unclear. Here we performed whole-cell patch-clamp recording and morphological reconstruction of cortical principal neurons in postsurgical brain tissue from drug-resistant epilepsy patients. Quantitative analyses revealed distinct morphological and electrophysiological characteristics of the upper layer dysmorphic neurons in type II FCD, including an enlarged soma, aberrant dendritic arbors, increased current injection for rheobase action potential firing, and reduced action potential firing frequency. Intriguingly, the upper layer dysmorphic neurons received decreased glutamatergic and increased GABAergic synaptic inputs that were coupled with upregulation of the Na+-K+-Cl- cotransporter. In addition, we found a depolarizing shift of the GABA reversal potential in the CamKII-cre::PTENflox/flox mouse model of drug-resistant epilepsy, suggesting that enhanced GABAergic inputs might depolarize dysmorphic neurons. Thus, imbalance of synaptic excitation and inhibition of dysmorphic neurons may contribute to seizure genesis in type II FCD.
Animals
;
Drug Resistant Epilepsy/surgery*
;
Epilepsy/pathology*
;
Malformations of Cortical Development/pathology*
;
Malformations of Cortical Development, Group I
;
Mice
;
Neurons/pathology*
;
Seizures/pathology*
2.Expression of cation chloride cotransporter (NKCC1/KCC2) in brain tissue of children with focal cortical dysplasia type Ⅱ.
Yan LI ; Yun Lin LI ; Yong Ling LIU ; Jing FU ; Wei Wei ZHANG ; Yue Shan PIAO
Chinese Journal of Pathology 2022;51(11):1123-1128
Objective: To investigate the expression of cation chloride cotransporter (NKCC1/KCC2) in the neurons from cerebral lesions of children with focal cortical dysplasia (FCD) type Ⅱ, to provide a morphological basis for revealing the possible mechanism of epilepsy. Methods: Eight cases of FCD type Ⅱ diagnosed at Beijing Haidian Hospital, Beijing, China and 12 cases diagnosed at Xuanwu Hospital, Capital Medical University, Beijing, China from February 2017 to December 2019 were included. The expression of NKCC1 and KCC2 in FCD type Ⅱa and FCD type Ⅱb was detected using immunohistochemistry and double immunohistochemical stains. The average optical density of NKCC1 in dysmorphic neurons and normal neurons was also determined using immunohistochemical staining in FCD type Ⅱa (10 cases). Results: The patients were all younger than 14 years of age. Ten cases were classified as FCD type IIa, and 10 cases as FCD type Ⅱb. NKCC1 was expressed in the cytoplasm of normal cerebral cortex neurons and KCC2 expressed on cell membranes. In dysmorphic neurons of FCD type Ⅱa, expression of NKCC1 increased, which was statistically higher than that of normal neurons (<i>P<i>0.01). Aberrant expression of KCC2 in dysmorphic neurons was also noted in the cytoplasm. In the FCD Ⅱb type, the expression pattern of NKCC1/KCC2 in dysmorphic neurons was the same as that of FCD type Ⅱa. The aberrant expression of NKCC1 in balloon cells was negative or weakly positive on the cell membrane, while the aberrant expression of KCC2 was absent. Conclusions: The expression pattern of NKCC1/KCC2 in dysmorphic neurons and balloon cells is completely different from that of normal neurons. The NKCC1/KCC2 protein-expression changes may affect the transmembrane chloride flow of neurons, modify the effect of inhibitory neurotransmitters γ-aminobutyric acid and increase neuronal excitability. These effects may be related to the occurrence of clinical epileptic symptoms.
Child
;
Humans
;
Brain/pathology*
;
Cations/metabolism*
;
Chlorides/metabolism*
;
Epilepsy/metabolism*
;
Malformations of Cortical Development, Group I/metabolism*
;
Solute Carrier Family 12, Member 2/metabolism*
;
Symporters/metabolism*
3.Activation of mTOR in maldeveloped balloon cells and dysmorphic neurons of type II focal cortical dysplasia.
Kun LIN ; Yuan-xiang LIN ; De-zhi KANG ; Zhong-xing YE ; Xing-fu WANG
Chinese Journal of Pathology 2013;42(5):311-315
OBJECTIVETo investigate whether mammalian target of rapamycin (mTOR) kinase was abnormally activated in maldeveloped balloon cells and dysmorphic neurons of focal cortical dysplasia (FCD) with refractory epilepsy.
METHODSA total of 12 archival cases of FCD typeIIwith medically intractable epilepsy treated between 2008 and 2010 were retrieved. Perilesional brain tissue was used as control specimens (n = 8). The expression of phosphorylated p-AKT (Ser473), p-mTOR (Ser2448) and p-P70S6K (Thr389) was investigated by imunocytochemistry.
RESULTSThe expression of p-AKT (Ser473), p-mTOR (Ser2448) and p-P70S6K (Thr389) was found in meldeveloped balloon cells and dysmorphic neurons of FCD. A weak stain in a small amount of pyramid neurons was also found in the control group.
CONCLUSIONAbnormal activation of mTOR in maldeveloped balloon cells and dysmorphic neurons of FCD may be a key molecular mechanism underlying the histological changes and repeated seizures.
Adolescent ; Adult ; Brain Diseases ; metabolism ; pathology ; Child, Preschool ; Epilepsy ; metabolism ; pathology ; Female ; Glial Fibrillary Acidic Protein ; metabolism ; Humans ; Immunohistochemistry ; Male ; Malformations of Cortical Development ; metabolism ; pathology ; Malformations of Cortical Development, Group I ; Nestin ; metabolism ; Neurons ; metabolism ; Phosphorylation ; Proto-Oncogene Proteins c-akt ; metabolism ; Ribosomal Protein S6 Kinases, 70-kDa ; metabolism ; TOR Serine-Threonine Kinases ; metabolism ; Young Adult
4.Clinicopathologic and radiologic features of focal cortical dysplasia.
Hai-xia CHENG ; Shu-guang CHU ; Hong CHEN ; Ji XIONG ; Jing-jing ZHU ; Chao LI ; Yin WANG
Chinese Journal of Pathology 2011;40(9):630-631
Adolescent
;
Adult
;
Antigens, Nuclear
;
metabolism
;
Brain Diseases
;
complications
;
diagnosis
;
pathology
;
surgery
;
Brain Neoplasms
;
pathology
;
Child
;
Child, Preschool
;
Diagnosis, Differential
;
Epilepsy
;
etiology
;
Female
;
Ganglioglioma
;
pathology
;
Glial Fibrillary Acidic Protein
;
metabolism
;
Humans
;
Infant
;
Magnetic Resonance Imaging
;
Male
;
Malformations of Cortical Development
;
classification
;
complications
;
diagnosis
;
pathology
;
surgery
;
Malformations of Cortical Development, Group I
;
Microtubule-Associated Proteins
;
metabolism
;
Neoplasms, Neuroepithelial
;
pathology
;
Nerve Tissue Proteins
;
metabolism
;
Neurofilament Proteins
;
metabolism
;
Retrospective Studies
;
Vimentin
;
metabolism
;
Young Adult
5.Hypomelanosis of Ito
Pandare SUGATHAN ; André GRABOWSKI
Brunei International Medical Journal 2012;8(3):139-144
Hypomelanosis of Ito (HI) is a rare neurocutaneous syndrome with characteristic whirled hypopigmented skin lesions and neurological manifestations. Less consistently, there may be non-neurological manifestations that include ophthalmic, musculoskeletal, craniofacial, cardiac, genitourinary, and gastrointestinal involvements. We report a case of HI, with typical skin lesions in association with hemimegalencephaly, seizures and mental retardation along with the hitherto unreported repetitive hand movements such as seen in Rett syndrome.
Hemimegalencephaly
;
Ito syndrome
;
Pigmentation disorders
6.A case of tuberous sclerosis with pulmonary involvement.
Jong Ho AHN ; Gee Young SUH ; Young Whan KIM ; Young Soo SHIM ; Keun Youl KIM ; Yong Chol HAN
Tuberculosis and Respiratory Diseases 1992;39(5):433-437
No abstract available.
Tuberous Sclerosis*
7.A Case of Tuberous Sclerosis.
Ju Kyeong LEE ; Kwang Soo HWANG ; Kyung Sook CHO ; Doo Sung MOON ; Chong Dae CHO
Journal of the Korean Pediatric Society 1985;28(5):514-517
No abstract available.
Tuberous Sclerosis*
8.A Clinical Investigation on 10 Patients of Tuberous Sclerosis.
Hee Jung CHUNG ; Myung Jin KIM ; Chang Jun COE
Journal of the Korean Pediatric Society 1983;26(4):373-379
No abstract available.
Humans
;
Tuberous Sclerosis*
9.Two cases of pulmonary lymphangioleiomyomatosis associated with tuberous sclerosis.
Jeong Cheon AHN ; Weon Yong JOH ; Kwang Ho IN ; Kyung Ho KANG ; Se Hwa YOO
Tuberculosis and Respiratory Diseases 1992;39(6):542-547
No abstract available.
Lymphangioleiomyomatosis*
;
Tuberous Sclerosis*
10.Pulmonary lymphangioleiomyomatosis as a pulmonary manifestation of tuberous sclerosis: a case report.
Young Rahn LEE ; Eun Young KANG ; Nam Joon LEE ; Won Hyuck SUH
Journal of the Korean Radiological Society 1991;27(2):252-254
No abstract available.
Lymphangioleiomyomatosis*
;
Tuberous Sclerosis*